Current State of Orthobiologics in Treatment of Knee Osteoarthritis—Future Directions
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27114738 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Woojin Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Warren Alpert Medical School, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Biological Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As the population ages, the incidence and prevalence of musculoskeletal degeneration, such as osteoarthritis, increase. While the currently accepted treatment options provide symptomatic and functional improvement, they do not halt the progression of osteoarthritis. This results in the eventual need for surgery for many patients with advanced osteoarthritis. Due to the seemingly inevitable progression of OA, many clinicians and researchers have shifted their focus to regenerative therapies. Orthobiologics, a specific type of regenerative therapy designed to treat orthopedic conditions, has been gaining traction in recent years due to the utilization of autologous biological substances and synthetic peptides in healing musculoskeletal injuries and degenerative conditions. Orthobiologics can be distinguished into one of four classes: cell-based, biologic fluids-based, matrix-based, molecular-based, and based on their composition. In this review, key examples of each class, mechanism of action, and current clinical data for each agent are examined. Limitations of current orthobiologics involve a lack of standardization in the preparation and administration of each agent, as well as uniformity in assessment endpoints across different clinical studies. Lastly, we will discuss future directions of orthobiologics as a therapy for the treatment of osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
- Department of Anesthesia, Critical Care, and Pain Medicine, McGovern Medical School, UTHealth, Houston, TX 77030, USA.
- Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.
- Spine and Nerve Center of the Virginias, West Virginia University, Health Sciences Campus, Charleston, WV 25301, USA.
- Department of Anesthesiology, The University of Kansas School of Medicine, Kansas City, KS 66045, USA.
ORCID-Profile: Jamal J Hasoon, Dawood Sayed, Franzes Anne Z Liongson, Elizabeth Hatfield, Alan D Kaye, Zachary L McCormick, Robert Jason Yong, Christopher L Robinson
Zitieren
APA
Lee, W., Ruan, Q. Z., Hasoon, J. J., Kulich, R. J., Deer, T. R., Sayed, D., Liongson, F. A. Z., Hatfield, E., Guirguis, M., Kaye, A. D., McCormick, Z. L., Yong, R. J., & Robinson, C. L. (2026). Current State of Orthobiologics in Treatment of Knee Osteoarthritis—Future Directions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27114738
Vancouver
Lee W, Ruan QZ, Hasoon JJ, Kulich RJ, Deer TR, Sayed D, et al. Current State of Orthobiologics in Treatment of Knee Osteoarthritis—Future Directions. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27114738
BibTeX
@article{Lee2026,
author = {Lee, Woojin and Ruan, Qing Zhao and Hasoon, Jamal J and Kulich, Ronald J and Deer, Timothy R and Sayed, Dawood and Liongson, Franzes Anne Z and Hatfield, Elizabeth and Guirguis, Maged and Kaye, Alan D and McCormick, Zachary L and Yong, Robert Jason and Robinson, Christopher L},
title = {Current State of Orthobiologics in Treatment of Knee Osteoarthritis—Future Directions},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27114738}
}
EUVIMED